Juvenile myelomonocytic leukemia (JMML) is a deadly pediatric leukemia driven by RAS pathway mutations, of which >35% are gain-of-function in PTPN11. This evidence concerns the gene PTPN11 and juvenile myelomonocytic leukemia.